A detailed history of Vinva Investment Management LTD transactions in Alkermes Plc. stock. As of the latest transaction made, Vinva Investment Management LTD holds 6,658 shares of ALKS stock, worth $205,998. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,658
Previous 10,332 35.56%
Holding current value
$205,998
Previous $377 Million 29.83%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.01 - $28.55 $84,538 - $104,892
-3,674 Reduced 35.56%
6,658 $264 Million
Q2 2024

Aug 13, 2024

SELL
$23.21 - $27.24 $91,470 - $107,352
-3,941 Reduced 27.61%
10,332 $377 Million
Q1 2024

May 13, 2024

BUY
$26.4 - $32.56 $182,503 - $225,087
6,913 Added 93.93%
14,273 $592 Million
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $172,003 - $211,084
7,360 New
7,360 $299 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.08B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Vinva Investment Management LTD Portfolio

Follow Vinva Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vinva Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Vinva Investment Management LTD with notifications on news.